Sastasundar Ventures Limited — Important, 02-05-2025: General Updates

Genu Path Labs, a subsidiary of Sastasundar Ventures, is cutting its paid-up equity by 90% (from Rs. 19.75 Cr to Rs. 1.97 Cr) by cancelling shares and writing off Rs. 38.93 Cr of accumulated losses against securities premium. This move is to strengthen the balance sheet and improve net worth without changing management or promoter stakes.